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http://dx.doi.org/10.1016/j.jmii.2013Background/Purpose: Influenza infection has different clinical presentations and outcomes in
children and adults, and bacterial coinfection is associated with significantly higher morbidity
and mortality. This study compared the clinical features in children and adults hospitalized for
influenza virus infection and the role of concomitant bacteremia.
Methods: A retrospective observational cohort study was conducted by a review of medical re-
cords of all consecutive patients admitted for influenza infection between April 1, 2009 and
February 28, 2011.
Results: Of the 1203 patients, 76.2% were children, and ranged in age from 1 month to 99 years,
with a mortality of 3.1% for adults; no children died. Pneumonia, acute respiratory distress
syndrome, acute respiratory failure, septic shock, and cardiovascular complications were more
common in adults. Bacteremia was more common in adults than in children (3.5% vs. 0.4%).
C-reactive protein (CRP) > 4 mg/dL and a longer hospital stay occurred more often in children
with bacteremia than in the group without bacteremia. In adults with bacteremia, acute res-
piratory failure, septic shock, and cardiovascular complications were more common, with a
mortality of 50% versus 1.4% compared with those without bacteremia, and thrombocytopenia
and increased CRP were independent risk factors. Using receiver operating characteristic anal-
ysis, CRP  14 mg/dL had a sensitivity of 90.0% and a specificity of 80.0%.Infectious Diseases, Department of Internal Medicine, Mackay Memorial Hospital, Number 92,
ipei, Taiwan.
rg.tw (C.-P. Liu).
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Clinical characteristics of influenza virus infection 519Conclusion: Influenza infection in adults is associated with increased risk of complications,
bacteremia, and mortality compared with that in children. Bacteremia in adults with influenza
is associated with increased complications and mortality; thrombocytopenia and elevated CRP
levels could identify those at risk.
Copyright ª 2013, Taiwan Society of Microbiology. Published by Elsevier Taiwan LLC. All rights
reserved.Background
Influenza is an acute infectious respiratory disease of viral
cause that occurs annually in outbreaks, epidemics, and oc-
casionally pandemics of varying severity and attack rates
depending on the influenza virus subtype involved.1 Even
though the mortality associated with epidemics is relatively
low, the total number of fatalitiesmaybehuge.2 In the recent
pandemic, influenza A H1N1 virus has been estimated to
cause 18,499 deaths in 214 different countries for the period
April, 2009 to August 1, 2010.3 The very young, the very old,
and persons with chronic medical conditions (pulmonary,
cardiovascular, liver, renal and neurologic diseases, diabetes
mellitus, or immunosuppression) have an increased risk of
hospitalization and mortality from influenza virus infec-
tion.2,4 In the setting of a severe pandemic, hospitals face an
enormous burden of patients,with a huge influx of individuals
requiring intensive care.5 Influenza also imposes a huge
financial burden on healthcare systems and society overall.1
Bacterial coinfection in influenza virus infection has
been associated with significantly higher morbidity and
mortality among patients in the intensive care unit.6 Data
on pediatric mortality associated with influenza in the
United States have shown an increase in the rate of bac-
terial coinfection, from 6e36% between 2004e2005 and
2006e2007.7 Severe complicated influenza infection,
defined by influenza-like illnesses with evidence of pneu-
monia, neurologic symptoms, myocarditis, pericarditis, or
invasive bacterial infection, has been a notifiable disease in
Taiwan since 2003.8 Children and adults have different
clinical presentations and outcomes in influenza infection,
and many studies on bacterial coinfection in influenza virus
infection have focused on bacterial pneumonia, whereas
only a few dealt with concomitant bacteremia.
The purposes of this study were to first compare the risk
factors, clinical features, and complications in children and
adults hospitalized for influenza infection, and second, to
determine the clinical features and role of concomitant
bacteremia in these patients.Methods
Study setting
Mackay Memorial Hospital is a 2000-bed tertiary referral
hospital in Taiwan, with 54 beds in the adult medical inten-
sive care unit and 19 beds in the pediatric intensive care unit.
This retrospective, observational cohort study was con-
ducted by reviewing the medical records of all consecutive
patients admitted for influenza infection between April 1,2009 and February 28, 2011. Only patients with clinical
features of influenza, and diagnosis confirmed by positive
rapid antigen test, virus culture, or real-time polymerase
chain reaction test were included. Patients with inade-
quate medical records were excluded. This study was
approved by the institutional review board of our hospital.
Definitions
Children were defined as age 18 years or younger, and
adults were older than 18 years. Data were collected by
reviewing the medical records and included demographic
characteristics, medical history, and laboratory data,
including antimicrobial susceptibility data. Risk factors for
severe complications from influenza were defined based on
those listed by the United States Advisory Committee on
Immunization Practices.9 These risk factors included
chronic pulmonary (including asthma) or cardiovascular
(excluding hypertension), renal, hepatic, neurological/
neuromuscular, hematologic, or metabolic disorders
(including diabetes mellitus), immunosuppression; and
residency in nursing homes and other long-term care fa-
cilities.9 Immunocompromised status was defined as the
presence of a hematologic malignancy, active cancer, or
human immunodeficiency virus infection, or treatment with
long-term corticosteroids, immunosuppressive therapy, or
cytotoxic chemotherapy. In patients with bacteremia, data
were collected from blood cultures done at presentation or
within 24 hours of admission and during the course of
their hospital stay. In adults, leukopenia was defined as a
total white blood cell (WBC) count < 4000/mL and throm-
bocytopenia as a total platelet count < 100  103/mL. In
children, leukopenia was defined as a total WBC
count < 4000/mL and thrombocytopenia as a total platelet
count < 100  103/mL. Elevated plasma C-reactive protein
(CRP) was defined as CRP > 1 mg/dL. In adults, sepsis was
defined as a documented infection with one or more of the
following: core temperature > 38.3C or < 36C, heart rate
> 90 beats/minute, respiratory rate > 20 breaths/minute
or partial pressure of CO2 in arterial blood (PaCO2) < 32 mm
Hg, and a WBC count > 12,000/mL or <4000/mL or >10%
band forms. In children, sepsis was defined as signs and
symptoms of inflammation plus infection with hyperthermia
or hypothermia, tachycardia, and at least one of the
following indications of altered organ dysfunction: altered
mental state, hypoxemia, increased serum lactate levels,
or bounding pulses. Septic shock was defined as sepsis with
acute circulatory failure characterized by persistent arte-
rial hypotension unexplained by other causes (following the
criteria of the 2001 SCCM/ESICM/ACCP/ATS/SIS Interna-
tional Sepsis Definitions Conference).10 Clinically significant
520 C.-H. Leung et al.bacteremia or bloodstream infection (BSI) was defined as
the isolation of bacteria from one or more blood cultures
from a patient with associated relevant symptoms and signs
of systemic infection. Bacteremia was considered to be
community-acquired if a blood culture that yielded positive
findings was obtained within 48 hours of hospital admission,
and was not associated with any procedure performed after
hospital admission; and healthcare-associated (HCA) if the
blood culture was obtained more than 48 hours after hos-
pitalization. The BSIs caused by coagulase-negative staph-
ylococci and other bacteria of saprophytic skin flora were
excluded. Severity of illness was assessed by means of the
acute physiology and chronic health evaluation (APACHE) II
score.
Statistical analysis
All the analyses were performed using SPSS 15 (SPSS Inc.,
Chicago, IL, USA). Patients’ characteristics were expressed
either as mean  standard deviation with interquartile
range (IQR; continuous variables) or frequency with per-
centage (categorical variables). Subgroup analysis was
performed among adult patients. Characteristics between
different groups were further compared using Student t
test or Fisher’s exact test as appropriate. Variables with
p < 0.05 by bivariate analyses were further included in the
multivariate regression model. Logistic regression was
applied to identify the risk factors for bacteremia. The
results were presented as odds ratios (OR) and their cor-
responding 95% confidence intervals (CI).
Results
From April 1, 2009 to February 28, 2011, 7782 patients were
treated at the emergency department and as outpatients,
and 1360 patientswere hospitalized for laboratory-confirmed
viral influenza infection at our hospital. After excluding pa-
tients with inadequate medical records; data from 1203 pa-
tients hospitalized for influenza infection were available for
analysis. As shown in Fig. 1, trends of influenza infection over
the study period were similar between pediatric and adult
patients. Thehighestmonthly incidences recordedwere from
August 2009 to November 2009, and in January 2011.
Demographic and clinical characteristics of children and
adults hospitalized for influenza infection are shown in
Table 1. The age range was from 1 month to 99 years, and
children made up 76.2% of the hospitalized individuals.Figure 1. Monthly incidence of influenza infection in chil-
dren and adults during the study period.Influenza A was the predominant type in both adults and
children, and more male children than adults were hospi-
talized for influenza. Overall, 67.7% (n Z 814) of the pa-
tients, including 72.5% (n Z 665) of children and 52.1%
(n Z 149) of adults, had no risk factors, whereas among
adults, 12.2% (n Z 35) had two or more risk factors
compared with 4.4% of children (n Z 40). In children,
chronic lung disease (bronchial asthma) was the most
common risk factor, followed by neurologic disease and
heart disease; in adults, diabetes mellitus was the most
common risk factor, followed by chronic lung disease, heart
disease, and neurologic disease. Thrombocytopenia,
increased CRP, pneumonia, acute respiratory distress syn-
drome (ARDS), acute respiratory failure, septic shock,
cardiovascular complications, and bacteremia occurred
more often in adults than in children. More adults required
intensive care unit (ICU) admission, extracorporeal mem-
brane oxygenation (ECMO) use, and a longer hospital stay
than in children. Mortality was 3.1% for adults, whereas no
children died of influenza infection. Oseltamivir was the
only antiviral agent used in all patients, including 95.1% of
children (872 of 917), and all adults.
CRP > 4 mg/dL and a longer hospital stay were more
common in children with bacteremia than in those without
bacteremia (Table 2). None of the children with bacteremia
had complications or required ICU admission. Bacteremia
occurred in 10 adults and was more common in influenza B
than influenza A (3 of 17, 17.7% vs. 7 of 269, 2.6%, respec-
tively, p Z 0.001) Adults with bacteremia were older, and
liver cirrhosis was more common than in those without
bacteremia, as were leukocytosis, thrombocytopenia, and
elevated CRP> 4 mg/dL (60.0% vs. 18.8%, 44.4% vs. 3.4% and
90.0% vs. 47.0%, respectively). Acute respiratory failure,
cardiovascular complications, septic shock, use of ECMO and
longer ICU stay were also more common in adults with
bacteremia, who also had an increased mortality (50.0% vs.
1.4%) compared with the nonbacteremic group.
Children with bacteremia had no risk factors, and all had
influenza A virus infection and community-acquired
bacteremia (Table 3). The bacteria isolated most often in
children was Streptococcus pneumoniae (nZ 2, 50.0%). All
were treated with oseltamivir, and 75.0% (3 of 4) received
antibiotics. One or more risk factors were present in 70.0%
of adults (7 of 10) with bacteremia (Table 4), and 70.0% (7
of 10) had influenza A virus infection. The most common
risk factors were cardiovascular disease and diabetes mel-
litus (n Z 4, 40.0% for both), followed by kidney disease
and liver cirrhosis (n Z 3, 30.0% for both). The bacteria
isolated most often in adults were Acinetobacter bau-
mannii and Escherichia coli (n Z 3, 30.0% for both). In
adults, 90.0% of BSI (9 of 10 patients) was community-
acquired. HCA infection was present in two patients with
bacteremia who died: patient Number 4 had A. baumannii
bacteremia; and patient Number 8 initially had community-
acquired BSI with Serratia marcescens, and later developed
HCA infection with A. baumannii bacteremia. The other
three adults with bacteremia who died had community-
acquired BSI: patient Number 1 had Enterobacter cloacae
(extended spectrum b-lactamase (ESBL) strain) bacter-
emia; patient Number 7 had A. baumannii bacteremia, and
patient Number 10, who was initially treated at a local
medical dispensary with oseltamivir without antibiotic use,
Table 1 Demographic and clinical characteristics of children and adults hospitalized for viral influenzaa
Variables Children (n Z 917) Adults (n Z 286) Total (n Z 1203) p
Age (y) 6.7  4.1 (3.6e9.2) 50.9  22.3 (29.3e69.4) 17.2  22.0 (4.4e16.9) <0.001
Sex, male 497 (54.2) 127 (44.4) 624 (51.9) 0.004
Influenza, type A 756 (82.4) 269 (94.1) 1025 (85.2) <0.001
Underlying disease
Chronic heart disease 33 (3.6) 44 (15.4) 77 (6.4) <0.001
Chronic lung disease 153 (16.7) 46 (16.1) 199 (16.5) 0.856
Chronic kidney disease 8 (0.9) 27 (9.4) 35 (2.9) <0.001
Liver cirrhosis 1 (0.1) 7 (2.4) 8 (0.7) <0.001
Diabetes mellitus 1 (0.1) 54 (18.9) 55 (4.6) <0.001
Immunosuppression 22 (2.4) 26 (9.1) 48 (4.0) <0.001
Neurological disease 65 (7.1) 32 (11.2) 97 (8.1) 0.034
Laboratory findings
Leukopenia 83 (9.2) 25 (8.7) 108 (9.1) 0.833
Thrombocytopenia 17 (1.9) 13 (4.8) 30 (2.6) <0.001
Elevated CRP 388 (44.1) 221 (84.7) 609 (53.4) <0.001
Complications
Pneumonia 487 (53.1) 201 (70.3) 688 (57.2) <0.001
ARDS 1 (0.1) 11 (3.8) 12 (1.0) <0.001
Acute respiratory failure 5 (0.5) 27 (9.4) 32 (2.7) <0.001
Septic shock 0 (0.0) 21 (7.3) 21 (1.7) <0.001
Neurological complications 30 (3.3) 10 (3.5) 40 (3.3) 0.851
Cardiovascular complication 5 (0.5) 32 (11.2) 37 (3.1) <0.001
Length of hospital stay (d) 4.2  2.8 (3e5) 8.0  12.2 (3e8) 5.1  6.6 (3e5) <0.001
Mortality 0 (0.0) 9 (3.1) 9 (0.7) < 0.001
Bacteremia 4 (0.44) 10 (3.5) 14 (1.2) <0.001
ECMO use 1 (0.1) 4 (1.4) 5 (0.4) 0.013
ICU stay 9 (1.0) 38 (13.3) 47 (3.9) <0.001
a LeukopeniaZ WBC count < 4000/mL; thrombocytopeniaZ platelet count < 100  103/mL; elevated C-reactive protein (CRP)Z CRP
>1 mg/dL.
Data are presented as mean  standard deviation with interquartile range (IQR) or n (%).
ARDS Z acute respiratory distress syndrome; ECMO Z extracorporeal membrane oxygenation; ICU Z intensive care unit.
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failure on admission with blood culture positive for S.
pneumoniae and later developed ventilator-associated
pneumonia and multisystem organ failure (MSOF). Adults
with bacteremia who died had a CRP range of
14.4e24.8 mg/dL, and an APACHE II score range of 23e35;
and all had influenza A infection, pneumonia, septic shock,
and acute respiratory failure. Blood cultures in all three
patients positive for A. baumannii were carbapenem
resistant, and all died. All adults with bacteremia were
treated with antibiotics, and the majority of patients who
died had inadequate initial empiric antibiotic treatment
before the availability of blood culture results.
In the multivariate analysis, type B influenza, thrombo-
cytopenia, and increased CRP were independently associ-
ated with bacteremia, as shown in Table 5. Because CRP was
a significant predictor of bacteremia by multivariate anal-
ysis, receiver operating characteristic (ROC) analyses were
performed for CRP, and CRP  14 mg/dL had a sensitivity of
90.0% and a specificity of 88.0% (data not shown).Discussion
Influenza infection in adults was associated with an
increased risk of pneumonia, ARDS, acute respiratoryfailure, septic shock, and cardiovascular complications
compared with children in our study. The mortality for
adults with influenza was 3.1%, and no child died of influ-
enza infection. Bacteremia was more common in adults
than in children hospitalized for influenza infection (3.5%
vs. 0.4%). Although the rate of bacteremia was low, there
was an increase in septic shock (60.0% vs. 5.4%), acute
respiratory failure (50.0% vs. 8.0%), cardiovascular compli-
cations (60.0% vs. 9.4%), and mortality (50.0% vs. 1.4%) in
adults with bacteremia compared to the nonbacteremic
group, underscoring the important role of bacteremia in
influenza virus infection. Other studies have reported
increased complications in influenza infection associated
with bacterial coinfection. In patients with critical illness
from the 2009 pandemic influenza A (pH1N1) virus infec-
tion, 24.2% had bacteremia, and patients with bacterial
coinfection were more likely to present with shock, have a
longer duration of ICU care, require mechanical ventilation,
and have a higher mortality rate (31%).6 Hospitalization for
viral infection with or without bacterial coinfection has
been shown to be associated with an increased risk of
mortality, pneumonia, ARDS, respiratory failure, multi-
system organ failure, and septic shock.11
In our study, the rate of bacteremia in children was low
(0.4%). In children with pH1N1 infection, bacterial coin-
fection occurred in 1.3%.12 The bacteria isolated most
Table 2 Comparison of children and adults hospitalized for influenza infection with and without bacteremiaa
Variables Children (n Z 917) Adults (n Z 286)
No
(n Z 913)
Yes
(n Z 4)
p No
(n Z 276)
Yes
(n Z 10)
p
Age (y) 6.7  4.1 (3.6e9.2) 4.1  1.4 (3.3e4.8) 0.199 50.3  22.3 (29.0e69.4) 67.8  13.5 (53.4e84.5) 0.014
Sex, male 493 (54.0) 4 (100.0) 0.129 122 (44.2) 5 (50.0) 0.755
Influenza, type A 752 (82.4) 4 (100.0) > 0.99 262 (94.9) 7 (70.0) 0.016
Underlying disease
Chronic heart disease 33 (3.6) 0 (0.0) > 0.99 40 (14.5) 4 (40.0) 0.051
Chronic lung disease 153 (16.8) 0 (0.0) > 0.99 44 (15.9) 2 (20.0) 0.666
Chronic kidney disease 8 (0.9) 0 (0.0) > 0.99 24 (8.7) 3 (30.0) 0.058
Liver cirrhosis 1 (0.1) 0 (0.0) > 0.99 4 (1.4) 3 (30.0) 0.001
Diabetes mellitus 1 (0.1) 0 (0.0) > 0.99 50 (18.1) 4 (40.0) 0.098
Neuromuscular disease 65 (7.1) 0 (0.0) > 0.99 31 (11.2) 1 (10.0) > 0.99
Laboratory findings
Leukocytosis 121 (13.4) 0 (0.0) > 0.99 52 (18.8) 6 (60.0) 0.006
Thrombocytopenia 17 (1.9) 0 (0.0) > 0.99 9 (3.4) 4 (44.4) <0.001
CRP > 4 (mg/dL) 98 (11.2) 2 (66.7) 0.036 118 (47.0) 9 (90.0) 0.009
CRP (mg/dL) 2.0  3.8 (0.3e2.1) 3.6  2.0 (1.5e5.4) 0.447 6.1  6.7 (1.5e7.5) 17.3  7.9 (14.4e23.5) <0.001
Complications
Pneumonia 483 (52.9) 4 (100.0) 0.127 194 (70.3) 7 (70.0) > 0.99
ARDS 1 (0.1) 0 (0.0) > 0.99 10 (3.6) 1 (10.0) 0.329
Acute respiratory failure 5 (0.5) 0 (0.0) > 0.99 22 (8.0) 5 (50.0) 0.001
Septic shock 0 (0.0) 0 (0.0) NA 15 (5.4) 6 (60.0) <0.001
Neurological complications 30 (3.3) 0 (0.0) > 0.99 9 (3.3) 1 (10.0) 0.304
Cardiovascular complications 5 (0.5) 0 (0.0) > 0.99 26 (9.4) 6 (60.0) <0.001
Length of hospital stay (d) 4.2  2.8 (3.0e5.0) 7.0  3.4 (4.5e9.5) 0.046 7.8  12.3 (3.0e8.0) 13.0  8.3 (5.0e17.0) 0.188
Mortality 0 (0.0) 0 (0.0) NA 4 (1.4) 5 (50.0) <0.001
Heart failure 0 (0.0) 0 (0.0) NA 13 (4.7) 2 (20.0) 0.091
ECMO 1 (0.1) 0 (0.0) > 0.99 2 (0.7) 2 (20.0) 0.006
ICU stay 9 (1.0) 0 (0.0) > 0.99 33 (12.0) 5 (50.0) 0.005
a Leukocytosis Z WBC count >12,000/mL; thrombocytopenia Z platelet count < 100  103/mL.
Data are presented as mean  standard deviation with interquartile range (IQR) or n (%).
ARDS Z acute respiratory distress syndrome; CRP Z C-reactive protein; ECMO Z extracorporeal membrane oxygenation; ICU Z intensive care unit; NA Z not applicable.
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Table 3 Clinical features, blood culture results, and outcome of children with influenza and bacteremia
Case no. Age (y) Sex Risk factors Blood culture organism Complications ICU stay Infection source
1 6 M none Roseomonas nil nil Bloodstreama
2 3 M none S. pneumoniae nil nil Pneumonia
3 3 M none S. viridans nil nil Oral ulcer
4 3 M none S. pneumoniae nil nil Pneumonia
a No other identifiable infection source.
ICU Z intensive care unit; S. pneumoniae Z Streptococcus pneumoniae; S. viridans Z Streptococcus viridans.
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pneumoniae. However, in critically ill children during the
2009e2010 influenza pandemic, approximately 5% of the
patients had bacteremia within 72 hours of pediatric
intensive care unit (PICU) admission, and Staphylococcus
aureus was the most common bacteria identified.13 The
most common bacteria isolated in our adults with
bacteremia were A. baumannii and E. coli, whereas in
critically ill patients with 2009 pH1N1, S. aureus was the
most common pathogen in bacteremia, followed by S.
pneumoniae.6 Antibiotic resistance was an important
factor in adults with bacteremia. Multiresistant Enter-
obacteriaceae and carbapenem-resistant A. baumannii
were among the bacteria isolated in most adults with
bacteremia who died (80%; 4 of 5 patients). ESBLs and
ampC b-lactamases (AmpCs) are among common plasmid-
mediated b-lactamases rapidly spreading among Enter-
obacteriaceae and resulting in resistance to several b-
lactam agents.14,15 In A. baumannii, carbapenem resis-
tance is due mostly to carbapenemases16,17 or to syner-
gistic effects between carbapenemases that hydrolyzeTable 4 Clinical features, blood culture results, and outcome i
Case
no.
Age
(y)
Sex Risk factors Blood culture organ
1 70 M CVD, DM, ESRD Enterobacter cloac
2 67 F None E. coli
3 68 M CVD, COPD, DM, ESRD K. pneumoniae
4 50 M None A. baumannii
5 84 F BA, CVD, CVA, ESRD,
Liver cirrrhosis
P. mendocina
6 61 F DM E.coli
7 52 M Liver cirrhosis A. baumannii
8 84 M COPD, Liver cirrhosis Serratia marcescen
Cholangio-carcinoma A.baumannii
9 84 F CVD, DM E. coli
10 53 F None S. pneumoniae
A. baumannii Z Acinetobacter baumannii; AE of COPD Z acute exa
fibrillation; ARDSZ acute respiratory distress syndrome; ARFZ acute
COPD Z chronic obstructive pulmonary disease; CVA Z cerebrovasc
(excluding hypertension); DMZ diabetes mellitus; E. coliZ Escherich
ICUZ intensive care unit; K. pneumoniaeZ Klebsiella pneumoniae;
mendocina; S. pneumoniae Z Streptococcus pneumoniae.carbapenems and decreased expression of certain
penicillin-binding proteins or other outer membrane
proteins.18,19
Overall, 95.1% of children in our study received oselta-
mivir treatment, including all patients with bacteremia.
Varying rates of antiviral use have been reported in other
studies, including 88.2% (5.8% antiviral started prior to PICU
admission)13 and 98.7%.12 All adults in our study received
antiviral treatment, which is higher than in other studies. In
patients with pH1N1 infection, 7% received antiviral treat-
ment for influenza prior to ICU admission, and almost all
received antiviral agents while in the ICU6 and 52% of adults
with severe influenza received oseltamivir.20 In Taiwan,
Centers for Disease Control, Republic of China (R.O.C.) of-
fers reimbursement for antiviral use for diagnosed influenza
infection during the influenza season; those having influenza
infection with other comorbidity and on self-payment. Early
initiation of oseltamivir treatment has been shown to be
beneficial in patients with influenza, with an increased risk
of severe disease when treatment was started 5 days after
illness onset.21n adults with influenza and bacteremia
ism Complications ICU
stay
Mortality Infection
source
ae Septic shock ARF Yes Yes Bed sore
Septic shock, Af No No Urinary tract
infection
AE of COPD No No Pneumonia
Septic shock, ARF,
ARDS, MSOF
Yes Yes Pneumonia
Acute asthma
attack
No No Pneumonia
No No Urinary tract
infection
ARF, septic shock Yes Yes Pneumonia
s ARF, septic shock,
Af, liver failure
Yes Yes Biliary tract
infection
Pneumonia
No No Urinary tract
infection
ARDS, ARF, septic
shock, MSOF
Yes Yes Pneumonia
cerbation of chronic obstructive pulmonary disease; Af Z atrial
respiratory failure, requiring ventilation; BAZ bronchial asthma;
ular accident; CVD Z chronic significant cardiovascular disease
ia coli; ESRDZ end-stage renal disease, on regular hemodialysis;
MSOFZ multisystem organ failure; P. mendocinaZ Pseudomonas
Table 5 Multivariate logistic regression model of risk
factors for bacteremia in adult patients with influenza
infection
Parameter OR 95% CI of OR p
Age (y) 1.03 0.98e1.08 0.192
Influenza, type A vs. B 0.05 0.004e0.59 0.018
Liver cirrhosis 13.84 0.53e361.94 0.115
Leukocytosis (> 12,000/mL) 3.40 0.22e51.55 0.378
Thrombocytopenia
(< 100  103/mL)
39.65 2.44e645.24 0.010
CRP (mg/dL) 1.18 1.06e1.31 0.003
CIZ confidence interval; CRPZ C-reactive protein; ORZ odds
ratio.
524 C.-H. Leung et al.In the bacteremic group, 75% of children and all adults
received antibiotics. In other studies, antibacterial treat-
ment was used in 92% of cases, and in 100% of fatal cases of
adults hospitalized with severe influenza.20 In children
hospitalized for pH1N1infection, 80% received antibacterial
agents.12 The administration of inadequate antimicrobial
treatment to critically ill patients with BSIs was shown to be
associated with greater hospital mortality compared with
adequate antimicrobial treatment of BSIs.22 In addition to
antiviral treatment, early empiric antibiotic use should be
considered for hospitalized patients with severe influenza
infection who are at an increased risk of bacterial lower
respiratory tract infections and bacteremia.
Risk factors more common in adults than in children with
influenza included chronic heart disease, chronic kidney
disease, liver cirrhosis, diabetes mellitus, immunosuppres-
sion, and neurologic disease. However, older age and liver
cirrhosis were the only risk factors that appeared more
frequently in adults with bacteremia than in the non-
bacteremic group, in this study. Heart disease, lung dis-
ease, diabetes mellitus, renal disease, rheumatologic
disease, dementia, stroke, pregnancy, and immunosup-
pression are all risk factors for influenza complications.4 In
adults with blood cultures performed at the emergency
department, older patients (60 years) and those with
diabetes mellitus were found to have a higher risk of
bacteremia.23 Although influenza B was independently
associated with bacteremia in adults, all those who died
had influenza A virus infection.
More than 65% of cases of bacteremia are associated
with thrombocytopenia. The mechanism underlying
thrombocytopenia in the absence of disseminated intra-
vascular coagulation may be related to the suppression of
platelet production, increased platelet utilization, and
immune phenomena.24 CRP values in most acute viral in-
fections are < 2e4 mg/dL. A value > 10 mg/dL is more
likely to be associated with bacterial infection, although
infections due to certain viruses can cause elevated CRP
levels.25 Other studies identified CRP as a risk factor for
bacteremia.23,26 In our study, thrombocytopenia and
increased CRP levels were independently associated with
bacteremia in adults with influenza infection, and could
help clinicians to identify those at increased risk of
bacteremia.
The highest incidences of influenza infection in our study
were from August 2009 to December 2009, which coincidedwith the 2009 pandemic influenza A (H1N1) virus infection.
Another high incidence occurred in December 2010, consis-
tent with an increase in influenza infection during winter.
For influenza, the highest seasonal rate was found to be in
the winter and the lowest seasonal rate was in the summer,
and widespread morbidity and mortality occur, not only
through infection but via bacterial superinfection. Knowl-
edge of seasonal variations in the incidence of sepsis and
severe sepsis would have important implications for public
health, hospital resource utilization, and clinical research.27
No child died of influenza infection in our study.
Influenza-associated deaths are uncommon among chil-
dren. Annual mean influenza-associated mortality rates for
underlying pneumonia and influenza deaths in persons
younger than 1 year and age 1e4 years were 0.3 and 0.2
deaths per 100 000 person-years, respectively; compared to
22.1 deaths per 100,000 person-years in persons 65 years or
older, during the 1990s.28 In children hospitalized for pH1N1
infection, the mortality rate was 2.6%11 and 8.9% for criti-
cally ill children.13
There were some limitations in our study. Our study was
retrospective. The incidence of influenza and bacteremia
may be underestimated because some patients with influ-
enza may have had negative rapid antigen tests and blood
cultures. This was a single-center study, and further studies
focusing on the role of bacteremia in influenza infection
would provide more data.
In conclusion, influenza infection in adults is associated
with an increased risk of complications, bacteremia, and
mortality compared with children. Although the incidence
of bacteremia in influenza infection is low; bacteremia in
adults is associated with a significant increase in acute
respiratory failure, septic shock, and mortality. Thrombo-
cytopenia and elevated CRP levels were independent risk
factors for concomitant bacteremia in adult patients with
influenza infection.References
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